The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population

被引:2
|
作者
Ng, Wai-Yoong [1 ]
Lim, Daniel Yan-Zheng [2 ,3 ]
Tan, Si-Yu [1 ]
Chang, Jason Pik-Eu [4 ]
Krishnamoorthy, Thinesh Lee [4 ]
Lim, Chee-Hooi [4 ]
Tan, Damien Meng-Yew [4 ]
Ekstrom, Victoria Sze-Min [4 ]
Goh, George Boon-Bee [4 ]
Cheah, Mark Chang-Chuen [4 ]
Kumar, Rajneesh [4 ]
Yeo, Chin-Pin [1 ]
Tan, Chee-Kiat [4 ,5 ]
机构
[1] Singapore Gen Hosp, Dept Clin Pathol, Singapore, Singapore
[2] Singapore Gen Hosp, Med Board, Hlth Serv Res Unit, Singapore, Singapore
[3] Duke NUS Med Sch, Med Acad Clin Programme, Singapore, Singapore
[4] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore
[5] Academia, Dept Gastroenterol & Hepatol, Level 3,20 Coll Rd, Singapore 169856, Singapore
关键词
DES-GAMMA-CARBOXYPROTHROMBIN; ALPHA-FETOPROTEIN;
D O I
10.47102/annals-acadmedsg.2022351
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:108 / 110
页数:3
相关论文
共 50 条
  • [1] Impact of PIVKA-II in diagnosis of hepatocellular carcinoma
    Zakhary, Nadia I.
    Khodeer, Sherif M.
    Shafik, Hanan E.
    Malak, Camelia A. Abdel
    JOURNAL OF ADVANCED RESEARCH, 2013, 4 (06) : 539 - 546
  • [2] THE SIGNIFICANCE OF PIVKA-II TO HEPATOCELLULAR CARCINOMA PROGNOSIS
    Shamsdin, S. A.
    Zahmatkeshan, M.
    Badiee, P.
    Hashemzadeh, Z.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S311 - S311
  • [3] Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma
    Guarneri, V.
    Loggi, E.
    Serra, C.
    Vukotic, R.
    Cevenini, M.
    Cursaro, C.
    Scuteri, A.
    Vitale, G.
    Margotti, M.
    Galli, S.
    Andreone, P.
    CLINICA CHIMICA ACTA, 2019, 493 : S147 - S147
  • [4] Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma
    Guarneri, Valeria
    Loggi, Elisabetta
    Serra, Carla
    Vukotic, Ranka
    Cevenini, Monica
    Cursaro, Carmela
    Scuteri, Alessandra
    Vitale, Giovanni
    Margotti, Marzia
    Galli, Silvia
    Galli, Claudio
    Andreone, Pietro
    JOURNAL OF HEPATOLOGY, 2020, 73 : S631 - S632
  • [5] Evaluation of PIVKA-II efficiency in the diagnosis of early hepatocellular carcinoma
    Saitta, Carlo
    Raffa, Giuseppina
    di Tocco, Francesca Casuscelli
    Brancatelli, Santa
    Alibrandi, Angela
    Raimondo, Giovanni
    Pollicino, Teresa
    HEPATOLOGY, 2015, 62 : 1134A - 1134A
  • [6] Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma
    Guarneri, Valeria
    Loggi, Elisabetta
    Ramacieri, Giuseppe
    Serra, Carla
    Vukotic, Ranka
    Vitale, Giovanni
    Scuteri, Alessandra
    Cursaro, Carmela
    Margotti, Marzia
    Galli, Silvia
    Caracausi, Maria
    Brodosi, Lucia
    Gabrielli, Filippo
    Andreone, Pietro
    CANCERS, 2025, 17 (02)
  • [7] CLINICOPATHOLOGICAL SIGNIFICANCE OF PIVKA-II AND AFP IN HEPATOCELLULAR-CARCINOMA
    NAKAGAWA, T
    SEKI, T
    SHIRO, T
    WAKABAYASHI, M
    ITOH, T
    IMAMURA, M
    TAMAI, T
    SHIOZAKI, Y
    INOUE, K
    OKAMURA, A
    HEPATOLOGY, 1995, 22 (04) : 322 - 322
  • [8] PIVKA-II IS A USEFUL TOOL FOR THE DIAGNOSIS OF EARLY HEPATOCELLULAR CARCINOMA
    Saitta, C.
    Raffa, G.
    Casuscelli, F.
    Brancatelli, S.
    Alibrandi, A.
    Raimondo, G.
    Pollicino, T.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E30 - E30
  • [9] The utility of PIVKA-II as a biomarker for treatment response in hepatocellular carcinoma
    Patricia Varquez, Charmaine
    Eternity Labio, Madalinee
    GUT, 2023, 72 (SUPPL_1) : A173 - A173
  • [10] Histological study of PIVKA-II expression in hepatocellular carcinoma and adenomatous hyperplasia
    Miskad, UA
    Yano, Y
    Nakaji, M
    Kishi, S
    Itoh, H
    Kim, SR
    Ku, YS
    Kuroda, Y
    Hayashi, Y
    PATHOLOGY INTERNATIONAL, 2001, 51 (12) : 916 - 922